ZZCovery
Natural health product licensed in Canada
- Other names
- ZZzCovery
- Licence holder
- Crosscor Inc.
- NPN or DIN-HM
- 80061747
- Status
- Inactive licence
- Licence date
- 10 June 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rhodiola rosea Source : Rhodiola rosea - Racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 101.58 milligramme Potency : 3 % Rosavin | 16.93 milligramme | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 1 % Salidroside | Not specified | Not calculated |
| Acide gamma-aminobutyrique Source : Acide glutamique | 105.82 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 42.33 milligramme | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 0.63 milligramme | Not calculated |
| Curcuma longa Source : Curcuma longa - Racine | 40.21 milligramme | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 58.2 milligramme | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 2,100,000 FCC PU | Not calculated |
| Salix alba Source : Salix alba - Écorce de jeune branche Extract : Matériel brut sec Extraction ratio : 16.002:1 Dry plant equivalent : 762 milligramme Potency : 15 % Salicin | 47.62 milligramme | Not calculated |
| Withania somnifera Source : Withania somnifera - racine | 21.16 milligramme | Not calculated |
| Panax ginseng Source : Panax ginseng - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 63.48 milligramme Potency : 4 % Total ginsenosides | 15.87 milligramme | Not calculated |
| Matricaria chamomilla Source : Matricaria chamomilla, fleur | 42.33 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to temporarily promote relaxation. Helps to increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Provides antioxidants for the maintenance of good health. Used in herbal medicine to help relieve minor pain, swelling and inflammation (anti-inflammatory).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061747
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.